Navigation Links
No 'July phenomenon' for neurosurgery patients, reports Neurosurgery

Philadelphia, Pa. (September 20, 2012) For patients undergoing neurosurgery at teaching hospitals, there's no "July phenomenon" of increased death and complication rates when new residents start their training, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The risk of adverse outcomes after common brain and spinal procedures are no different in July compared to any other month, according to the research by Dr. Brian L. Hoh of University of Florida and colleagues.

Risks of Neurosurgery Don't Increase in July

To investigate whether there was a real "July phenomenon" affecting neurosurgical risks, the researchers analyzed data from a nationwide hospital database (the National Inpatient Sample) from 1998 to 2008. They focused on nearly 860,000 hospital admissions for four different types of common neurosurgery procedures: nontraumatic brain hemorrhage (bleeding), central nervous system (CNS) trauma, CNS tumors, and hydrocephalus ("water on the brain").

For procedures performed in teaching hospitalswhere residents are involved in patient care, including surgeryrates of complications and death were compared for the month of July versus all other months. The analysis included adjustment for patient and hospital characteristics.

The results showed no significant difference in the risk of death for operations performed in July. For example, in patients undergoing surgery for CNS tumorsthe largest of the four categoriesthe mortality rate was 7.1 percent in July compared to 7.2 percent in all other months. The complication rate was 1.4 percent in July and in all other months.

Death and complication rates were also similar for July versus other months in the other three diagnostic categories. Analysis of patients treated at non-teaching hospitalswhich don't train residentsalso showed no significant differences in mortality or complications rates.

Previous studies have evaluated whether there is any evidence of a "July phenomenon" in various medical specialties. The results have been inconsistent, although most studies have found no difference in at the start of the academic year in Julywhen new graduates start residency training and current residents take on increased responsibilities. The new study is one of the few to look at whether there is any difference in the outcomes of common neurosurgery procedures related to the "July phenomenon."

Based on their large, nationwide study, Dr. Hoh and colleagues conclude, "No 'July phenomenon' was found for neurosurgical mortality or complications in patients with nontraumatic hemorrhage, CNS trauma, CNS tumor, or hydrocephalus." The researchers acknowledge some weaknesses of their studyparticularly the fact that it couldn't detect "near-miss" errors that don't lead to death or serious complications. They also note, "The lack of a July phenomenon may be attributable to the increased supervision by faculty and more senior residents during the start of the academic year."


Contact: Connie Hughes
Wolters Kluwer Health

Related medicine news :

1. JCI early table of contents for July 16, 2012
2. JCI early table of contents for July 9, 2012
3. Leave 4th of July Fireworks to Professionals
4. Light Fireworks Not Cigarettes this Fourth of July with South Beach Smoke
5. San Francisco is Hosting EB-5 Conference July 19, 2012
6. Brian Su Hosts EB-5 Training Camp in California July 19, 2012
7. Liquidation Channel Announces its Fourth of July Celebrations Featuring Diamond Smackdown
8. True-Dose to Exhibit Liquid Pet Supplements at the Cardinal Health Retail Business Conference in Orlando, FL on July 11-14
9. New Plants from Hines Growers Add Firework Colors to Fourth of July Celebrations and Summer Fun
10. Mid-America Hand to Shoulder Clinic Offers Tips for a Safe Fourth of July
11. Dr. Sandy T. Feldman Offers Tips for 4th July Fireworks Safety
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: